Digitalization clinical trials


Digitalization of clinical trials

How new technologies enhance the future of health care

Executive summary

Medical care has improved dramatically in recent decades, leading to a better quality of life for patients and their relatives. However, biopharma companies admit that there is still progress to be made with regard to the clinical trial process, particularly in terms of high Research and Development (R&D) costs, risk of failure, and reliability of data due to archaic procedures. It would seem that the current way of conducting clinical trials is nearing an end. As the world progresses to a more digitalized era, clinical trials are driven by the adoption of new technologies, which quickly accelerate the digital transformation of their processes.

PDF - 231kb

Inside Magazine issue 19, November 2018

Inside is Deloitte’s quarterly magazine offering an exclusive insight into best practices, trends and opportunities faced by our clients across all industries.

Inside focuses on the main hot topics relevant for the market (Asset management, Banking, Insurance, Public sector, Healthcare, Private equity, Real estate, TMT, Manufacturing and consumer business, Transport and logistics).

PDF - 8.6mb
Did you find this useful?